INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 65 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $138,195 | -53.3% | 249,000 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $296,000 | +88.5% | 249,000 | 0.0% | 0.01% | +100.0% |
Q2 2022 | $157,000 | -50.8% | 249,000 | -11.1% | 0.00% | -33.3% |
Q1 2022 | $319,000 | +1.3% | 280,000 | +100.0% | 0.01% | 0.0% |
Q4 2021 | $315,000 | -77.2% | 140,000 | -65.3% | 0.01% | -76.9% |
Q3 2021 | $1,379,000 | -15.4% | 403,100 | -26.1% | 0.03% | -10.3% |
Q2 2021 | $1,630,000 | +22.8% | 545,300 | +32.7% | 0.03% | +16.0% |
Q1 2021 | $1,327,000 | +49.3% | 410,800 | -2.0% | 0.02% | +31.6% |
Q4 2020 | $889,000 | +81.1% | 419,300 | 0.0% | 0.02% | +72.7% |
Q3 2020 | $491,000 | +29.6% | 419,300 | 0.0% | 0.01% | +37.5% |
Q2 2020 | $379,000 | +10.5% | 419,300 | +2.3% | 0.01% | 0.0% |
Q1 2020 | $343,000 | -28.1% | 410,000 | -17.5% | 0.01% | +33.3% |
Q4 2019 | $477,000 | -6.8% | 496,900 | 0.0% | 0.01% | -14.3% |
Q3 2019 | $512,000 | -42.7% | 496,900 | 0.0% | 0.01% | -36.4% |
Q2 2019 | $894,000 | +7.5% | 496,900 | +12.3% | 0.01% | +10.0% |
Q1 2019 | $832,000 | +152.9% | 442,500 | +58.6% | 0.01% | +150.0% |
Q4 2018 | $329,000 | -73.6% | 279,000 | -39.2% | 0.00% | -66.7% |
Q3 2018 | $1,244,000 | +41.8% | 459,000 | 0.0% | 0.01% | +33.3% |
Q2 2018 | $877,000 | -9.0% | 459,000 | 0.0% | 0.01% | -10.0% |
Q1 2018 | $964,000 | +3.4% | 459,000 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $932,000 | +52.8% | 459,000 | 0.0% | 0.01% | +42.9% |
Q3 2017 | $610,000 | +86.0% | 459,000 | +119.6% | 0.01% | +75.0% |
Q2 2017 | $328,000 | -64.8% | 209,000 | -27.7% | 0.00% | -63.6% |
Q1 2017 | $933,000 | +135.0% | 289,000 | -1.6% | 0.01% | +120.0% |
Q4 2016 | $397,000 | -13.3% | 293,800 | 0.0% | 0.01% | -28.6% |
Q3 2016 | $458,000 | – | 293,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |